CVRx Reports Third Quarter 2024 Financial and Operating Results
Positive ▪️Revenue growth of 27% YoY to $13.4 million ▪️U.S. Heart Failure revenue increased 30% to $12.2 million ▪️Active implanting centers grew 31% to 208 ▪️Hospital reimbursement increased from $17-23K to $43K per procedure ▪️Secured Category I CPT codes for improved reimbursement ▪️Strong cash position of $100.2 million ▪️Gross margin maintained at 83%
Negative ▪️Net loss increased to $13.1 million from $9.0 million YoY ▪️SG&A expenses increased 38% to $21.6 million ▪️Cash burn of $10.4 million in Q3 ▪️Operating expenses guidance increased to $100 million ▪️Revenue guidance narrowed downward to $50.5-$51.5 million
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
HailTheApocalypse : should go up 1 to 2 dollars and 60 cents a share according to some analysts. might have to get me some. virtually that is lol.